{"name":"LivaNova","slug":"livanova","ticker":"LIVN","exchange":"NASDAQ","domain":"livanova.com","description":"LivaNova, plc is a medical device manufacturer that is a foreign domiciled company based in the U.K. for tax inversion purposes. With operational headquarters in the United States. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol \"LIVN\".","hq":"London, United Kingdom","founded":0,"employees":"3300","ceo":"Vladimir Makatsaria","sector":"Medical Devices / Neuromodulation","stockPrice":64.92,"stockChange":1.38,"stockChangePercent":2.17,"marketCap":"$3.6B","metrics":{"revenue":1388053000,"revenueGrowth":12.1,"grossMargin":68,"rdSpend":185764000,"netIncome":-242471000,"cash":635552000,"dividendYield":0,"peRatio":14.2,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"LivaNova Reports Fourth Quarter and Full Year 2023 Results","summary":"LivaNova reported fourth quarter and full year 2023 results, with revenue of $444.8 million and $1.7 billion, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"LivaNova Announces Agreement to Acquire Certain Assets from Medtronic","summary":"LivaNova announced an agreement to acquire certain assets from Medtronic, expanding its neuromodulation portfolio.","drugName":"","sentiment":"positive"},{"date":"2023-06-01","type":"regulatory","headline":"LivaNova Receives FDA Approval for SenTiva Pacemaker","summary":"LivaNova received FDA approval for its SenTiva pacemaker, a new generation of cardiac resynchronization therapy pacemakers.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPVFhoWTVtYktuTFprMkltWVBta0R3aHRwdXJPTGhBMVQ4UFpZYmhpdjdjalBIY1lmc0ZDa1Y1YzNHVHk2b19xUG5UOXFQM1hRTlZ6cDNFekFRbjJ1VWZQYWwzMHptRGJWaG13SVlja05MUG8tbF9CTk9SVGVJLXl5R0pzclVaRmxhTDRDdUd5aC1KdXFxM0ZfRHcxR1k4RHhhSUV0SGlOSmNGT21XSzhSZ1pyNF9XbUpudFVjeWhlX004UVBDUU5uMFNBZ0E4TDd3Qm93?oc=5","date":"2026-04-06","type":"pipeline","source":"MarketBeat","summary":"Allspring Global Investments Holdings LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat","headline":"Allspring Global Investments Holdings LLC Reduces Stake in LivaNova PLC $LIVN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPWjZOaVFxbDFadkVISlU5Y2hUSTZQQm5IY3o3YXM3bzZhV2dJT2J5V2h2R0xEX2FQMzYtdzFwcXllOHY5QlVWUmVfQUxWZzg3ZndraGREaEMtZXY5eWpMUzRTUU5mUTQ4S1hmNDU3SVJoNGlEdmpzb1JkbVpXRU9VMGJFMGNuRmgwYkI0bVpwUDZDR21HN3ZlTTdkZUNiNXdGS2ZHenhDTFljRFNBZExNaEY3a2d1dVRsRDViZUpTVXBDbHJC?oc=5","date":"2026-04-04","type":"deal","source":"MarketBeat","summary":"Exchange Traded Concepts LLC Buys New Shares in LivaNova PLC $LIVN - MarketBeat","headline":"Exchange Traded Concepts LLC Buys New Shares in LivaNova PLC $LIVN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNb1huR1NjU0w2YWw4emlibmE5cWJTS2xyMGpDcTVRamNfV1dZWnJHUzNLYkczVGxKMldWOUl1VkV5UnE3YjhqX1BGY0QtempKTWxKYmtjWmhtVnlDN01nYzJHa1VwSVBpbGhBQzN1TXh5QlVBbWdHNEhJYkJGcFZpeGNBR01keGlTLVJFZWtoTWhlWW10MHhVSUttUWJuZXFEMzlEdkdDQ1poRjBTd0MwV2l2OA?oc=5","date":"2026-03-19","type":"deal","source":"富途牛牛","summary":"Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81 - 富途牛牛","headline":"Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81 - 富途牛牛","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNaGJSbWMxTUc2ZHVhUW11Uk5ndkhjZ3o1WkRhZXRZVllpeEhnaGVkWXFaR3I1NWVnNVhVLTZIVTVxV0ZaMkxGdXVDUzJrdU5mTURkWTM2VDRmNTY5cjlEMlJnYlJGTnFKaG8wci0ySDRMaHEzOUFoN0NUcUVhbzczdmloQ2t3M2p5dzJzdU55czRhSmsxRmJHVGExZm5tT3hmVWRCcC16UlFpdmg4dEpRdWhZZjdTNU5XcUZvb3c4MmRDSWIydzdxeFdFTHRlX1Rqb2NzS1hfQjUtOEhZUzVISXdpUGk0UEZlVTUtSVJvcWNyZXc3cGhFZ21xaGRDOU5iMlZjaWctZGtLbm94NlRTN3dOUFowTHhGWXQxUERHSlZMVDJKQ1E?oc=5","date":"2026-03-19","type":"regulatory","source":"Business Wire","summary":"LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea - Business Wire","headline":"LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe O","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPWkZqS3JRV1dpZ2tKRktiM24yclRwT0pLR2pXZXU0ZmhLMm5tTzE5aHVZbXB4ZkNMMmE4VVRRcDh3eGEzWEQ0eEVNU0o5dmtIN2N5d3RrMWxPR2NxbXEwV3NpcWxCMlFoVVJCR3JTa1ctcEpSek9NYldNbUJyWFU1SkdhdTlucnltc3p6WnNoSmpCQkdpWmVZQkVOeTdxdy1FQjdxMHJJWFVRa1NtTkRfeU9ldVNtc2ZpVVZmYjVwbFJVR1k5YU4tVHhpVWpFNlk?oc=5","date":"2026-03-15","type":"pipeline","source":"MarketBeat","summary":"Boone Capital Management LLC Purchases Shares of 167,932 LivaNova PLC $LIVN - MarketBeat","headline":"Boone Capital Management LLC Purchases Shares of 167,932 LivaNova PLC $LIVN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNRTc2TllVcEgwXzBfOHFVMUdhT25pQi1HX0NyYl9nZTQwUF9NbFRVUk5OZktpTXM4TVFIaWRGSFJkN2R5ZzJNOWJXM0V0dldjeUM5WFpuT0ZqekJQUDVMcTdpb0pwNjI3Z0pqNkVZcFd5WVZpenpQUHJ3ejhhcGtwTTAyUE90dUFWQzZjVUZ1NWpWcWtLbHY4emQzeG94TnZ4cHhqV2ZwWUtGd09m?oc=5","date":"2026-02-27","type":"pipeline","source":"Seeking Alpha","summary":"LivaNova: Excellent Performer Too Expensive In 2026 (Rating Downgrade) (NASDAQ:LIVN) - Seeking Alpha","headline":"LivaNova: Excellent Performer Too Expensive In 2026 (Rating Downgrade) (NASDAQ:LIVN)","sentiment":"neutral"},{"date":"2026-02-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQakNxNGxNbUN1UUVaVDIyelpraVVFdXhCNXBtdEp6bDI3THEtNWJ1TmlxUnl1eE5HdElQR3IxSlZHVjRxV29jdFBaaGY2MGlVa2RzMElLZ2pWSnlJYkRFamhyY0JEekx0TnI5ZkVkN2RHT0VJS0d4SWZTajR3dldfYXgtR0liY3d5RDFJS19CTQ?oc=5","date":"2026-01-28","type":"pipeline","source":"Investor's Business Daily","summary":"IBD Stock Of The Day, LivaNova, Forms A Unique Base; Will New Opportunities Drive It Higher? - Investor's Business Daily","headline":"IBD Stock Of The Day, LivaNova, Forms A Unique Base; Will New Opportunities Drive It Higher? - Investor's Business Daily","sentiment":"neutral"},{"date":"2026-01-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSEJxVEowbDhZR2piNmFacHZyWGZjVFhwZnVITldmNjNKeUxvQzR3QzZOZVBpVm9ZZ3BRNTUyZ0I2SFhLUmdncTZpRTJPVVE0Q05wYUtnOTVNTFg0V29OblNIdUdaT0o3VjRUbXA3OUplRWVONnR5NkZaa2VtQ29LY2xMeTdfUUd1eXZSdmVwaXluLXRHV3hNSVNXS0F0MkYwTXhPcEZuQVRWZlFITzVuQ2EzUnJYVWxw?oc=5","date":"2025-11-24","type":"pipeline","source":"Stock Titan","summary":"LivaNova (Nasdaq: LIVN) wins CMS VNS Therapy outpatient pay hikes of up to 48% - Stock Titan","headline":"LivaNova (Nasdaq: LIVN) wins CMS VNS Therapy outpatient pay hikes of up to 48%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPYVlVTUw4QjRrTkJVcE1vRXNWcGMzdWtFQ2ktVWNXTktJd0RRYWRxVi1Xa1kweloxVmQtUVFVS01QT0RETE50cEJiOFN5NVJXRV9TZ2NjM3ZqMDF4U3o0MjRpaU93YkhNVnBYVUNBRlhSdDJrcFF0VV9RQVR1cHI4dEdqbUhhNUdxTTNRQ0hMRUgtY0E?oc=5","date":"2025-11-15","type":"pipeline","source":"Seeking Alpha","summary":"LivaNova PLC (LIVN) Analyst/Investor Day - Slideshow (NASDAQ:LIVN) 2025-11-15 - Seeking Alpha","headline":"LivaNova PLC (LIVN) Analyst/Investor Day - Slideshow (NASDAQ:LIVN) 2025-11-15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOcnc1WDQtSmxyR3Y1Rk1uVHJnSTU4UC1QT3NiX1YtNUVneVRQbmdGTkVCdXoxamsxN2MwMUhqYXFrNzFaS3k1eW5EY21DOGdraXJsUHB4aVRXaC1jNUhJNkdEekZ2cnBoWXZXZmJGSTNmRHpzam5paW0xdTFEcTdjNXRVQ3hQZHlHTUJSekotXzVUaWpNYkE?oc=5","date":"2025-11-12","type":"pipeline","source":"MassDevice","summary":"LivaNova outlines plans for future growth at investor day event - MassDevice","headline":"LivaNova outlines plans for future growth at investor day event","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQdnJzN0dOZkZNbl80dTh0UWpFTFBmMXg3VHBEaDVUc2xEbEx4M25WenlRMkYybzl5ZHkzMHhkVFFOOGhzMHJIM01qSDJBRWZmTk9vaU5SRUItX2Z6ZWZiMmg3TTZUdm1iZ1Y0QXNETnZNandya3NDeVdUeWlpN3dnbm01LTNsUjTSAY8BQVVfeXFMTTRoQVJON2F4WlA1WWJhLTRWTER2ejlERUlueVBpMWc1eXo2c3FNYWU4Q3NOVy1qVUowelpnWTNOMEo2Zkpua01FVnVlRlQxU3dkSE5GeHBZazVHZ1VzeGtJZHdNZTRYaGdtcWVUcEdkRzJ4WWR5eWNMVkxTOFJucFdFUTlvYXI4Z3JlVXZ4RW8?oc=5","date":"2025-07-23","type":"deal","source":"Insider Monkey","summary":"10 Best Mid Cap Pharma Stocks to Buy - Insider Monkey","headline":"10 Best Mid Cap Pharma Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOa0QwRGtjTVNmeGRkQzg5VXltNGtZX3lfcEdaZW9ZbFpBZVQ2ZWpFMmxRcU9FaG83OXBPNGx5cTJ0M2FNOGZiSmsxME50bXFaZHlDMnFlcGs0eWp6U2tsaS1UZEkydlNOaWVjLXJOZmJVUmtrYk11aU9oek90VUlvQUpfSmQ5eXM?oc=5","date":"2025-07-07","type":"pipeline","source":"Seeking Alpha","summary":"LivaNova: The Sell-Off Is Excessive Here (NASDAQ:LIVN) - Seeking Alpha","headline":"LivaNova: The Sell-Off Is Excessive Here (NASDAQ:LIVN)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Medtronic","Boston Scientific","Abbott Laboratories"],"therapeuticFocus":["Neuromodulation","Cardiac Surgery"],"financials":{"source":"sec_edgar","revenue":1388053000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":1388053000,"period":"2025-12-31"},{"value":1253437000,"period":"2024-12-31"},{"value":1253437000,"period":"2024-12-31"},{"value":1153545000,"period":"2023-12-31"},{"value":1153545000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":185764000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-242471000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":2606053000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":64.92,"previousClose":63.54,"fiftyTwoWeekHigh":71.92,"fiftyTwoWeekLow":32.48,"fiftyTwoWeekRange":"32.48 - 71.92","fiftyDayAverage":64.88,"twoHundredDayAverage":56.85,"beta":0.97,"enterpriseValue":3273214720,"forwardPE":14.2,"priceToBook":2.96,"priceToSales":2.56,"enterpriseToRevenue":2.36,"enterpriseToEbitda":12.7,"pegRatio":0.73,"ebitda":257655008,"ebitdaMargin":18.6,"freeCashflow":834246656,"operatingCashflow":254340000,"totalDebt":433772000,"debtToEquity":36.1,"currentRatio":1.36,"returnOnAssets":5.2,"returnOnEquity":-19.2,"analystRating":"","recommendationKey":"none","numberOfAnalysts":11,"targetMeanPrice":79.91,"targetHighPrice":90,"targetLowPrice":67,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.4,"institutionHeldPercent":107,"sharesOutstanding":54689876,"floatShares":50956745,"sharesShort":2785113,"shortRatio":2.95,"shortPercentOfFloat":5.1,"epsTrailing":-4.45,"epsForward":4.58,"revenuePerShare":25.45,"bookValue":21.96,"officers":[{"age":52,"name":"Mr. Vladimir A. Makatsaria","title":"CEO & Director"},{"age":55,"name":"Mr. Alex  Shvartsburg C.M.A.","title":"Chief Financial Officer"},{"age":null,"name":"Mr. Ahmet  Tezel Ph.D.","title":"Chief Innovation Officer"},{"age":null,"name":"Mr. Franco  Poletti","title":"President of Cardiopulmonary Business Unit"},{"age":null,"name":"Ms. Lindsey  Little","title":"VP & Chief Accounting Officer"},{"age":null,"name":"Briana  Gotlin","title":"Vice President of Investor Relations"},{"age":null,"name":"Deanna  Wilke","title":"Vice President of Corporate Communications"},{"age":null,"name":"Mr. Philip  Kowalczyk","title":"Chief Strategy & Corporate Development Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.livanova.com","phone":"44 20 3325 0660"}}